Rehabilitation in Practice: Neurogenic lower urinary tract dysfunction and its management
- 28 June 2010
- journal article
- review article
- Published by SAGE Publications in Clinical Rehabilitation
- Vol. 24 (7) , 579-589
Abstract
This series of articles for rehabilitation in practice aims to cover a knowledge element of the rehabilitation medicine curriculum. Nevertheless they are intended to be of interest to a multidisciplinary audience. The competency addressed in this article is ‘the trainee consistent demonstrates a knowledge of the pathophysiology of various specific impairments including bladder dysfunction’ and ‘management approaches for specific impairments including bladder dysfunction’. The lower urinary tract (bladder and urethra) has two roles: storage of urine and emptying at appropriate times. The optimal and coordinated activity of the lower urinary tract is subject to a complex neural control which involves all levels of the nervous system, from cortex to peripheral innervation. The complexity of the neural control of lower urinary tract explains the high prevalence of urinary disturbances in neurologic disease. Information obtained from history taking and supplemented by use of a bladder diary forms the cornerstone of evaluation. Ultrasonography is used to assess the degree of incomplete bladder emptying, and for assessing the upper tracts. Urodynamic tests, with or without simultaneous fluoroscopic monitoring, assess detrusor and bladder outlet function and give fundamental information about detrusor pressure and thus the risk factor for upper tract damage. Impaired emptying is most often managed by clean intermittent self-catheterization and this should be initiated if the post-void residual urine is greater than 100 mL or exceeds one third of bladder capacity, or rarely if spontaneous voiding is dangerous due to high detrusor pressure. Storage symptoms are most often managed using antimuscarinic medications. Other options include desmopressin to reduce urine output or intradetrusor injection of botulinum toxin type A to reduce detrusor overactivity. Understanding of the underlying mechanism of lower urinary tract dysfunction is crucial for effective management.Keywords
This publication has 33 references indexed in Scilit:
- Clean intermittent self-catheterization in persons with multiple sclerosis: the influence of cognitive dysfunctionMultiple Sclerosis Journal, 2009
- Development and Validation of the Short Form of a Urinary Quality of Life Questionnaire: SF-QualiveenJournal of Urology, 2008
- A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Antimuscarinic Drugs for Overactive BladderEuropean Urology, 2008
- The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-AnalysisEuropean Urology, 2008
- Management of overactive bladder syndrome2007
- Recommandations du Groupe d’Études de Neuro-Urologie de Langue Française (GENULF) pour le suivi du blessé médullaire et du patient spina bifidaProgrès en Urologie, 2007
- Intravesical Oxybutynin: A Local Anesthetic Effect on Bladder C AfferentsJournal of Urology, 2003
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- Intravesical capsaicin for treatment of detrusor hyperreflexia.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Desmopressin: A new Principle for Symptomatic Treatment of Urgency and Incontinence in Patients with Multiple SclerosisScandinavian Journal of Urology and Nephrology, 1990